| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_465b4b36d2a561ee4b2f8979f182d92b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-958
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L29-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L29-08 |
| filingDate |
2011-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51bf56e3a7b26c9c3215bbdc210ebbcd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cde0fc7b9cb6b6114315c03486047934
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cabcbf393cc3248f9c349d27893c517 |
| publicationDate |
2016-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2578422-C2 |
| titleOfInvention |
Medicinal product with particle-free coating releasing active substance |
| abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to medicine, specifically to a body-contacting medicinal product such as a short-term implant and a long-term implant coated by at least one layer, which contains a molecular-disperse distributed or dissolved active substance in at least one carrier and optionally one or more additives; the above at least one layer is formed of abrasion-resistant solution in the form of a over-cooled melt, which optionally contains a crystallisation inhibitor. n EFFECT: coated implant makes it possible to transfer the active substance to vascular walls effectively and with no particles formed. n 10 cl, 18 ex |
| priorityDate |
2010-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |